Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astagen is a branded formulation of astaxanthin, a naturally occurring xanthophyll carotenoid known for its exceptionally high antioxidant capacity. Developed by Pharmaceutical General, it is marketed as a dietary supplement to combat oxidative stress and support various aspects of health, including ocular, dermatological, and cardiovascular functions. Astaxanthin's unique molecular structure allows it to span the cell membrane, providing protection against lipid peroxidation and neutralizing reactive oxygen species (ROS) more effectively than many other antioxidants like vitamin E or beta-carotene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astaxanthin (General Pharmaceuticals).